Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,08 USD | +16,12% | +2,86% | +96,36% |
Omzet 2024 * | 30 mln. 27,66 mln. | Omzet 2025 * | 18,75 mln. 17,29 mln. | Marktkapitalisatie | 39,86 mln. 36,75 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -35 mln. -32,27 mln. | Nettowinst (verlies) 2025 * | -70 mln. -64,55 mln. | EV/omzet 2024 * | -5,22 x |
Nettoliquiditeiten 2024 * | 196 mln. 181 mln. | Nettoliquiditeiten 2025 * | 302 mln. 278 mln. | EV/omzet 2025 * | -14 x |
K/w-verhouding 2024 * |
-1,71
x | K/w-verhouding 2025 * |
-0,9
x | Werknemers | 73 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 74,21% |
Recentste transcriptie over Xilio Therapeutics, Inc.
1 dag | +16,12% | ||
1 week | +2,86% | ||
3 maanden | +49,92% | ||
6 maanden | +3,85% | ||
Lopend jaar | +96,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
René Russo
CEO | Chief Executive Officer | 49 | 22-05-19 |
Kevin Brennan
DFI | Director of Finance/CFO | 54 | - |
Chief Tech/Sci/R&D Officer | - | 01-10-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Clancy
CHM | Chairman | 62 | 23-07-20 |
Daniel Curran
BRD | Director/Board Member | 57 | 01-12-20 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 15-09-22 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 1,08 | +16,12% | 229 612 |
30-05-24 | 0,9301 | -0,63% | 219 907 |
29-05-24 | 0,936 | +2,04% | 175 541 |
28-05-24 | 0,9173 | -12,64% | 633 729 |
24-05-24 | 1,05 | -1,87% | 111 384 |
uitgestelde koers Nasdaq, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+96,36% | 39,86 mln. | |
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |